Trademark: 86583883
Status Date
Monday, November 5, 2018
Filing Date
Wednesday, April 1, 2015
Published for Opposition
Tuesday, August 4, 2015
Abandoned Date
Monday, November 5, 2018
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Nov 5, 2018
Abandonment Notice Mailed - No Use Statement Filed
Nov 5, 2018
Abandonment - No Use Statement Filed
Feb 23, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2018
Extension 5 Granted
Feb 16, 2018
Extension 5 Filed
Feb 21, 2018
Case Assigned To Intent To Use Paralegal
Feb 16, 2018
Teas Change Of Correspondence Received
Feb 16, 2018
Teas Extension Received
Jan 3, 2018
Assignment Of Ownership Not Updated Automatically
Sep 7, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 5, 2017
Extension 4 Granted
Sep 5, 2017
Extension 4 Filed
Sep 5, 2017
Teas Extension Received
Jul 5, 2017
Automatic Update Of Assignment Of Ownership
Mar 15, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 14, 2017
Extension 3 Granted
Mar 8, 2017
Extension 3 Filed
Mar 8, 2017
Teas Extension Received
Mar 8, 2017
Automatic Update Of Assignment Of Ownership
Jan 30, 2017
Teas Change Of Correspondence Received
Sep 27, 2016
Notice Of Approval Of Extension Request E-Mailed
Sep 25, 2016
Extension 2 Granted
Sep 6, 2016
Extension 2 Filed
Sep 6, 2016
Teas Extension Received
May 21, 2016
Notice Of Approval Of Extension Request E-Mailed
May 20, 2016
Extension 1 Granted
Mar 29, 2016
Extension 1 Filed
May 16, 2016
Case Assigned To Intent To Use Paralegal
Apr 9, 2016
Notice Of Revival - E-Mailed
Apr 8, 2016
Extension Received With Teas Petition
Apr 8, 2016
Petition To Revive-Granted
Apr 8, 2016
Teas Petition To Revive Received
Sep 29, 2015
Noa E-Mailed - Sou Required From Applicant
Aug 4, 2015
Official Gazette Publication Confirmation E-Mailed
Aug 4, 2015
Published For Opposition
Jul 15, 2015
Notification Of Notice Of Publication E-Mailed
Jun 30, 2015
Law Office Publication Review Completed
Jun 29, 2015
Assigned To Lie
Jun 10, 2015
Approved For Pub - Principal Register
Jun 10, 2015
Examiner's Amendment Entered
Jun 10, 2015
Notification Of Examiners Amendment E-Mailed
Jun 10, 2015
Examiners Amendment E-Mailed
Jun 10, 2015
Examiners Amendment -Written
Jun 4, 2015
Assigned To Examiner
Apr 10, 2015
New Application Office Supplied Data Entered In Tram
Apr 4, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
